ASAI HIROAKI 朝井洋晶

Researcher Number	00726838
Affiliation (based on the past Project Information) *help	2019 – 2020: 国際医療福祉大学, 国際医療福祉大学三田病院, 准教授 2015 – 2018: 愛媛大学, 医学部附属病院, 講師(病院教員) 2015: 愛媛大学, 医学部附属病院, 講師(病院職員) 2014: 愛媛大学, 医学部附属病院, 助教(病院教員)
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related / Hematology / Tumor therapeutics
Keywords	Principal Investigator 細胞免疫療法 / 遺伝子改変T細胞療法 / WT1 / 多発性骨髄腫 / NY-ESO-1 / CAR-T / 化学療法抵抗性白血病 / 免疫チェックポイント阻害剤 / PD-1 / チェックポイント阻害剤 … More / PD1 / PD-L1 / Wilms tumor 1 / 白血病性幹細胞 Less

Development of novel CAR-T cell therapy for multiple myelomaPrincipal Investigator
- Principal Investigator
  
  Asai Hiroaki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  International University of Health and Welfare
  Ehime University
Development of novel redirected T cell-based adaptive immunotherapy to cure the chemotherapy-resistant leukemiaPrincipal Investigator
- Principal Investigator
  
  ASAI HIROAKI
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Ehime University
Development of redirected T cell-based adoptive immunotherapy targeting leukemia stem cellsPrincipal Investigator
- Principal Investigator
  
  ASAI HIROAKI
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Ehime University

All 2019 2015 Other

All Journal Article Presentation

[Journal Article] Direct comparisoin of target-reactivity and cross-reactivity induced by CAR-and BiTE-redirected T cells for the development of antibody-based T-cell therapy.2019
- Author(s)
  Masaki Maruta, Toshiki Ochi, Kazushi Tanimoto, Hiroaki Asai, et al.
- Journal Title
  
  Scientific reports
  
  Volume: 9 Issue: 1 Pages: 13293-13293
- DOI
  10.1038/s41598-019-49834-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08330, KAKENHI-PROJECT-18K08331, KAKENHI-PROJECT-18K08361, KAKENHI-PROJECT-18H02839, KAKENHI-PROJECT-18H02840, KAKENHI-PROJECT-17K09957
[Journal Article] Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.2015
- Author(s)
  Fujiwara H, Ochi T, Ochi F, Miyazaki Y, Asai H, Narita M, Okamoto S, Mineno J, Kuzushima K, Shiku H, Yasukawa M.
- Journal Title
  
  Leukemia
  
  Volume: 29(12) Issue: 12 Pages: 2393-2401
- DOI
  10.1038/leu.2015.155
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09506, KAKENHI-PROJECT-15H04858, KAKENHI-PROJECT-26670467, KAKENHI-PROJECT-26830109
[Presentation] TCR遺伝子改変HLAクラスI拘束性CD4陽性T細胞サブタイプ作成の試み
- Author(s)
  朝井洋晶、藤原弘、安川正貴ほか
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26830109

1. 安川正貴 (60127917)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. FUJIWARA Hiroshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

ASAI HIROAKI 朝井洋晶

Research Projects

Research Products

Co-Researchers

Development of novel CAR-T cell therapy for multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel redirected T cell-based adaptive immunotherapy to cure the chemotherapy-resistant leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of redirected T cell-based adoptive immunotherapy targeting leukemia stem cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Direct comparisoin of target-reactivity and cross-reactivity induced by CAR-and BiTE-redirected T cells for the development of antibody-based T-cell therapy.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] TCR遺伝子改変HLAクラスI拘束性CD4陽性T細胞サブタイプ作成の試み

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

ASAI HIROAKI 朝井 洋晶

Research Projects

Research Products

Co-Researchers

Development of novel CAR-T cell therapy for multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel redirected T cell-based adaptive immunotherapy to cure the chemotherapy-resistant leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of redirected T cell-based adoptive immunotherapy targeting leukemia stem cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Direct comparisoin of target-reactivity and cross-reactivity induced by CAR-and BiTE-redirected T cells for the development of antibody-based T-cell therapy.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Antileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.2015

Author(s)

Journal Title

DOI

Data Source

[Presentation] TCR遺伝子改変HLAクラスI拘束性CD4陽性T細胞サブタイプ作成の試み

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

ASAI HIROAKI 朝井洋晶